MARKET

GLMD

GLMD

Galmed Pharmaceu
NASDAQ
0.4000
+0.0386
+10.68%
After Hours: 0.3899 -0.0101 -2.53% 19:35 04/24 EDT
OPEN
0.3794
PREV CLOSE
0.3614
HIGH
0.4000
LOW
0.3556
VOLUME
51.65K
TURNOVER
0
52 WEEK HIGH
7.80
52 WEEK LOW
0.2600
MARKET CAP
2.40M
P/E (TTM)
-0.1603
1D
5D
1M
3M
1Y
5Y
Weekly Report: what happened at GLMD last week (0415-0419)?
Weekly Report · 3d ago
Hepion ends Phase 2 study for NASH drug due to cash restraints
Seeking Alpha · 5d ago
Weekly Report: what happened at GLMD last week (0408-0412)?
Weekly Report · 04/15 10:30
Why PriceSmart Shares Are Trading Higher By Around 5%; Here Are 20 Stocks Moving Premarket
PriceSmart, Inc. Posted better-than-expected earnings for its second quarter. The company reported quarterly sales of $1.29 billion. PriceSmart shares surged 4.6% to $86.90 in pre-market trading. Marin Software Incorporated shares rose 76.1% after the company announced upgrades to its Microsoft Corp advertising integration.
Benzinga · 04/10 12:12
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
Marin Software (NASDAQ:MRIN) stock is rocketing more than 67% after upgrading its integration with Microsoft Advertising. Shareholder meetings, clinical updates, an annual report and delisting plans are moving stocks this morning. The biggest pre-market stock movers on Wednesday morning are Marin Software and iCoreConnect.
Investorplace · 04/10 11:28
Madrigal announces US launch of NASH/MASH drug Rezdiffra
Healthcare Madrigal announces US launch of NASH/MASH drug Rezdiffra. The drug is now available in the US through a specialty pharmacy network. Other companies working on therapies for NASH and MASH include Eli Lilly and Novo Nordisk. MadrigAL is the first to receive FDA approval for the treatment of the disease.
Seeking Alpha · 04/09 14:03
Why Agenus Shares Are Trading Lower By Around 17%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Shares of Agenus Inc. (NASDAQ:AGEN) fell sharply during Monday's session. Auddia Inc. Shares jumped 231.7% to $4.72. The company announced a 1-for-20 reverse stock split of common stock.
Benzinga · 04/08 17:10
Weekly Report: what happened at GLMD last week (0401-0405)?
Weekly Report · 04/08 10:33
More
About GLMD
Galmed Pharmaceuticals is a Israeli-based clinical-stage biopharmaceutical company.The activiti of the Company is focused on the development therapy for treating liver diseases. Arachmol, the main product of Galmed Pharmaceuticals, is a liver-targeted stearoyl-coenzyme A desaturase1 used in oral therapy for the treatment of NASH (Non-alcoholic Steatohepatitis).

Webull offers Galmed Pharmaceuticals Ltd stock information, including NASDAQ: GLMD real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, GLMD stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading GLMD stock methods without spending real money on the virtual paper trading platform.